Literature DB >> 16055227

Down-regulation of brain nuclear factor-kappa B pathway in the cyclooxygenase-2 knockout mouse.

Jagadeesh S Rao1, Robert Langenbach, Francesca Bosetti.   

Abstract

Cyclooxygenase (COX) is the rate-limiting enzyme in the synthesis of prostaglandins (PGs) from arachidonic acid. Evidence suggests that neuronal COX-2 gene expression is mainly regulated by the transcription factor nuclear factor kappa-B (NF-kappaB). The present study was undertaken to determine whether there is a shared regulation of NF-kappaB or of nuclear factor of activated T-cells cytoplasmic (NFATc) with COX-2 and whether these transcription factors known to regulate COX-2 expression are altered in brain from COX-2 knockout (COX-2-/-) mice compared to wild type. We found a decrease in NF-kappaB DNA-protein binding activity, which was accompanied by a reduction of the phosphorylation state of both I-kappaBalpha and p65 proteins in the COX-2-/- mice. The mRNA and protein levels of p65 were also reduced in COX-2-/- mice, whereas total cytoplasmic I-kappaB protein level was not significantly changed. Taken together, these changes may be responsible for the observed decrease in NF-kappaB DNA binding activity. NF-kappaB DNA binding activity was selectively affected in the COX-2-/- mice compared to the wild type as there was no significant change in NFATc DNA binding activity. Overall, our data indicate that constitutive brain NF-kappaB activity is decreased in COX-2 deficient mice and suggest a reciprocal coupling between NF-kappaB and COX-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055227     DOI: 10.1016/j.molbrainres.2005.05.008

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis.

Authors:  Sang-Ho Choi; Robert Langenbach; Francesca Bosetti
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

Review 2.  Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models.

Authors:  Francesca Bosetti
Journal:  J Neurochem       Date:  2007-04-02       Impact factor: 5.372

3.  Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain.

Authors:  Christopher D Toscano; Vinaykumar V Prabhu; Robert Langenbach; Kevin G Becker; Francesca Bosetti
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

Review 4.  Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders.

Authors:  Rickinder Sethi; Nieves Gómez-Coronado; Adam J Walker; Oliver D'Arcy Robertson; Bruno Agustini; Michael Berk; Seetal Dodd
Journal:  Front Psychiatry       Date:  2019-09-04       Impact factor: 4.157

Review 5.  Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia.

Authors:  Sabrina H Ansarey
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

6.  RGS12 Is a Novel Critical NF-κB Activator in Inflammatory Arthritis.

Authors:  Gongsheng Yuan; Shuting Yang; Andrew Ng; Chuanyun Fu; Merry Jo Oursler; Lianping Xing; Shuying Yang
Journal:  iScience       Date:  2020-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.